2018 대한부정맥학회 심방세동 위험인자와 동반된 심혈관계 질환의 발견과 관리

키워드

참고문헌 (123)

1. Pathak RK, "Aggressive risk factor reduction study for atrial fibrillation and implications for the outcome of ablation: the ARREST-AF cohort study", J Am Coll Cardiol, 64, pp.2222~2231 (2014)[DOI]
2. Abed HS, "Effect of weight reduction and cardiometabolic risk factor management on symptom burden and severity in patients with atrial fibrillation: a randomized clinical trial", JAMA, 310, pp.2050~2060 (2013)[DOI]
3. Guha K, "Heart failure epidemiology: European perspective", Curr Cardiol Rev, 9, pp.123~127 (2013)[DOI]
4. Braunschweig F, "What are the costs of heart failure?", Europace, 13(Suppl 2), pp.ii13~ii17 (2011)[DOI]
5. Wodchis WP, "A review of the cost of atrial fibrillation", Value Health, 15, pp.240~248 (2012)[DOI]
6. Kotecha D, "Atrial fibrillation in heart failure: what should we do?", Eur Heart J, 36, pp.3250~3257 (2015)
7. Olsson LG, "Atrial fibrillation and risk of clinical events in chronic heart failure with and without left ventricular systolic dysfunction: results from the candesartan in heart failure-assessment of reduction in mortality and morbidity (CHARM) program", J Am Coll Cardiol, 47, pp.1997~2004 (2006)[DOI]
8. Kotecha D, "Atrial fibrillation and heart failure due to reduced versus preserved ejection fraction: a systematic review and meta-analysis of death and adverse outcomes", Int J Cardiol, 203, pp.660~666 (2016)[DOI]
9. Wang TJ, "Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: the framingham heart study", Circulation, 107, pp.2920~2925 (2003)[DOI]
10. Mamas MA, "A meta-analysis of the prognostic significance of atrial fibrillation in chronic heart failure", Eur J Heart Fail, 11, pp.676~683 (2009)[DOI]
11. Ponikowski P, "2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC", Eur Heart J, 37, pp.2129~2200 (2016)[DOI]
12. Lip GY, "European Heart Rhythm Association", Heart Failure Association joint consensus document on arrhythmias in heart failure, endorsed by the Heart Rhythm Society and the Asia Pacific Heart Rhythm Society, 2016, pp.18, 12~36
13. McMurray JJ, "Angiotensin-neprilysin inhibition versus enalapril in heart failure", N Engl J Med, 371, pp.993~1004 (2014)[DOI]
14. Kotecha D, "Efficacy of <TEX>${\beta}$<", TEX> blockers in patients with heart failure plus atrial fibrillation: an individual-patient data meta-analysis, 2014, pp.384, 2235~2243
15. Ziff OJ, "Safety and efficacy of digoxin: systematic review and meta-analysis of observational and controlled trial data", BMJ, 351, pp.h4451~ (2015)
16. Jones DG, "A randomized trial to assess catheter ablation versus rate control in the management of persistent atrial fibrillation in heart failure", J Am Coll Cardiol, 61, pp.1894~1903 (2013)[DOI]
17. Anselmino M, "Catheter ablation of atrial fibrillation in patients with left ventricular systolic dysfunction: a systematic review and meta-analysis", Circ Arrhythm Electrophysiol, 7, pp.1011~1018 (2014)[DOI]
18. Ganesan AN, "Catheter ablation of atrial fibrillation in patients with concomitant left ventricular impairment: a systematic review of efficacy and effect on ejection fraction", Heart Lung Circ, 24, pp.270~280 (2015)[DOI]
19. Khan MN, "Pulmonary-vein isolation for atrial fibrillation in patients with heart failure", N Engl J Med, 359, pp.1778~1785 (2008)[DOI]
20. Gupta S, "Tachycardia mediated cardiomyopathy: pathophysiology, mechanisms, clinical features and management", Int J Cardiol, 172, pp.40~46 (2014)[DOI]
21. Kusunose K, "Clinical utility of single-beat E", e' obtained by simultaneous recording of flow and tissue Doppler velocities in atrial fibrillation with preserved systolic function, 2009, pp.2, 1147~1156
22. Li C, "Will simultaneous measurement of E", e' index facilitate the non-invasive assessment of left ventricular filling pressure in patients with non-valvular atrial fibrillation?, 2010, pp.11, 296~301
23. Senechal M, "A simple Doppler echocardiography method to evaluate pulmonary capillary wedge pressure in patients with atrial fibrillation", Echocardiography, 25, pp.57~63 (2008)
24. Sohn DW, "Mitral annulus velocity in the evaluation of left ventricular diastolic function in atrial fibrillation", J Am Soc Echocardiogr, 12, pp.927~931 (1999)[DOI]
25. Wada Y, "Simultaneous Doppler tracing of transmitral inflow and mitral annular velocity as an estimate of elevated left ventricular filling pressure in patients with atrial fibrillation", Circ J, 76, pp.675~681 (2012)[DOI]
26. Kelly JP, "Patient selection in heart failure with preserved ejection fraction clinical trials", J Am Coll Cardiol, 65, pp.1668~1682 (2015)[DOI]
27. Schneider MP, "Prevention of atrial fibrillation by renin-angiotensin system inhibition a meta-analysis", J Am Coll Cardiol, 55, pp.2299~2307 (2010)[DOI]
28. Healey JS, "Prevention of atrial fibrillation with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: a meta-analysis", J Am Coll Cardiol, 45, pp.1832~1839 (2005)[DOI]
29. Jibrini MB, "Prevention of atrial fibrillation by way of abrogation of the renin-angiotensin system: a systematic review and meta-analysis", Am J Ther, 15, pp.36~43 (2008)[DOI]
30. Ducharme A, "Prevention of atrial fibrillation in patients with symptomatic chronic heart failure by candesartan in the candesartan in heart failure: assessment of reduction in mortality and morbidity (CHARM) program", Am Heart J, 152, pp.86~92 (2006)[DOI]
31. GISSI-AF Investigators, "Valsartan for prevention of recurrent atrial fibrillation", N Engl J Med, 360, pp.1606~1617 (2009)[DOI]
32. Goette A, "Angiotensin II-antagonist in paroxysmal atrial fibrillation (ANTIPAF) trial", Circ Arrhythm Electrophysiol, 5, pp.43~51 (2012)[DOI]
33. ACTIVE I Investigators, "Irbesartan in patients with atrial fibrillation", N Engl J Med, 364, pp.928~938 (2011)[DOI]
34. Swedberg K, "Eplerenone and atrial fibrillation in mild systolic heart failure: results from the EMPHASIS-HF (eplerenone in mild patients hospitalization and survIval study in heart failure) study", J Am Coll Cardiol, 59, pp.1598~1603 (2012)[DOI]
35. Bardy GH, "Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure", N Engl J Med, 352, pp.225~237 (2005)[DOI]
36. Strickberger SA, "Amiodarone versus implantable cardioverter-defibrillator: randomized trial in patients with nonischemic dilated cardiomyopathy and asymptomatic nonsustained ventricular tachycardia--AMIOVIRT", J Am Coll Cardiol, 41, pp.1707~1712 (2003)[DOI]
37. Torp-Pedersen C, "Dofetilide in patients with congestive heart failure and left ventricular dysfunction. Danish Investigations of arrhythmia and mortality on dofetilide study group", N Engl J Med, 341, pp.857~865 (1999)[DOI]
38. Roy D, "Rhythm control versus rate control for atrial fibrillation and heart failure", N Engl J Med, 358, pp.2667~2677 (2008)[DOI]
39. Di Biase L, "Ablation versus amiodarone for treatment of persistent atrial fibrillation in patients with congestive heart failure and an implanted device: results from the AATAC multicenter randomized trial", Circulation, 133, pp.1637~1644 (2016)[DOI]
40. Marrouche NF, "Catheter ablation for atrial fibrillation with heart failure", N Engl J Med, 378, pp.417~427 (2018)[DOI]
41. January CT, "2014 AHA", ACC, American Heart Association Task Force on practice guidelines and the Heart Rhythm Society, pp.Circulation, 2014[DOI]
42. Kirchhof P, "2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS", Eur Heart J, 37, pp.2893~2962 (2016)[DOI]
43. Manolis AJ, "Hypertension and atrial fibrillation: diagnostic approach, prevention and treatment. Position paper of the working group 'Hypertension Arrhythmias and Thrombosis' of the European society of hypertension", J Hypertens, 30, pp.239~252 (2012)[DOI]
44. Goette A, "Increased expression of extracellular signal-regulated kinase and angiotensin-converting enzyme in human atria during atrial fibrillation", J Am Coll Cardiol, 35, pp.1669~1677 (2000)[DOI]
45. Marott SC, "Antihypertensive treatment and risk of atrial fibrillation: a nationwide study", Eur Heart J, 35, pp.1205~1214 (2014)[DOI]
46. Wachtell K, "Angiotensin II receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol: the losartan intervention for end point reduction in hypertension (LIFE) study", J Am Coll Cardiol, 45, pp.712~719 (2005)[DOI]
47. SPRINT Research Group, "A randomized trial of intensive versus standard blood-pressure control", N Engl J Med, 373, pp.2103~2116 (2015)[DOI]
48. Whelton PK, "2017 ACC", AHA, ABC, pp.ACPM, AGS[DOI]
49. Furberg CD, "Prevalence of atrial fibrillation in elderly subjects (the cardiovascular health study)", Am J Cardiol, 74, pp.236~241 (1994)[DOI]
50. Nabauer M, "The registry of the german competence network on atrial fibrillation: patient characteristics and initial management", Europace, 11, pp.423~434 (2009)
51. Vahanian A, "Joint task force on the management of valvular heart disease of the European society of cardiology (ESC); European association for cardio-thoracic surgery (EACTS). Guidelines on the management of valvular heart disease (version 2012)", Eur Heart J, 33, pp.2451~2496 (2012)[DOI]
52. Nieuwlaat R, "Atrial fibrillation management: a prospective survey in ESC member countries: the Euro heart survey on atrial fibrillation", Eur Heart J, 26, pp.2422~2434 (2005)[DOI]
53. Nishimura RA, "2017 AHA", ACC focused update of the 2014 AHA, American Heart Association task force on clinical practice guidelines, pp.J Am Coll Cardiol, 2017[DOI]
54. Moretti M, "Prognostic significance of atrial fibrillation and severity of symptoms of heart failure in patients with low gradient aortic stenosis and preserved left ventricular ejection fraction", Am J Cardiol, 114, pp.1722~1728 (2014)[DOI]
55. Eguchi K, "Pre-operative atrial fibrillation as the key determinant of outcome of mitral valve repair for degenerative mitral regurgitation", Eur Heart J, 26, pp.1866~1872 (2005)[DOI]
56. Lim E, "Influence of atrial fibrillation on outcome following mitral valve repair", Circulation, 104(12 Suppl 1), pp.I59~I63 (2001)[DOI]
57. Maan A, "Impact of atrial fibrillation on outcomes in patients who underwent transcatheter aortic valve replacement", Am J Cardiol, 115, pp.220~226 (2015)[DOI]
58. Ngaage DL, "Prognostic implications of preoperative atrial fibrillation in patients undergoing aortic valve replacement: is there an argument for concomitant arrhythmia surgery?", Ann Thorac Surg, 82, pp.1392~1399 (2006)[DOI]
59. Ngaage DL, "Influence of preoperative atrial fibrillation on late results of mitral repair: is concomitant ablation justified?", Ann Thorac Surg, 84, pp.434~442 (2007)[DOI]
60. Barbash IM, "Predictors and clinical implications of atrial fibrillation in patients with severe aortic stenosis undergoing transcatheter aortic valve implantation", Catheter Cardiovasc Interv, 85, pp.468~477 (2015)[DOI]
61. Halperin JL, "Atrial fibrillation and stroke: new ideas, persisting dilemmas", Stroke, 19, pp.937~941 (1988)[DOI]
62. Vahanian A, "Guidelines on the management of valvular heart disease (version 2012): the joint task force on the management of valvular heart disease of the European society of cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)", Eur J Cardiothorac Surg, 42, pp.S1~S44 (2012)[DOI]
63. Molteni M, "The definition of valvular and non-valvular atrial fibrillation: results of a physicians' survey", Europace, 16, pp.1720~1725 (2014)[DOI]
64. Blackshear JL, "Appendage obliteration to reduce stroke in cardiac surgical patients with atrial fibrillation", Ann Thorac Surg, 61, pp.755~759 (1996)[DOI]
65. Szekely P, "Systemic embolism and anticoagulant prophylaxis in rheumatic heart disease", Br Med J, 1, pp.1209~1212 (1964)[DOI]
66. De Caterina R, "What is 'valvular' atrial fibrillation? A reappraisal", Eur Heart J, 35, pp.3328~3335 (2014)[DOI]
67. Schoen T, "Type 2 diabetes mellitus and risk of incident atrial fibrillation in women", J Am Coll Cardiol, 60, pp.1421~1428 (2012)[DOI]
68. Chung MK, "C-reactive protein elevation in patients with atrial arrhythmias: inflammatory mechanisms and persistence of atrial fibrillation", Circulation, 104, pp.2886~2891 (2001)[DOI]
69. Donath MY, "Type 2 diabetes as an inflammatory disease", Nat Rev Immunol, 11, pp.98~107 (2011)[DOI]
70. Du X, "Risks of cardiovascular events and effects of routine blood pressure lowering among patients with type 2 diabetes and atrial fibrillation: results of the ADVANCE study", Eur Heart J, 30, pp.1128~1135 (2009)[DOI]
71. Olson TM, "Human K(ATP) channelopathies: diseases of metabolic homeostasis", Pflugers Arch, 460, pp.295~306 (2010)[DOI]
72. Rizzo MR, "Autonomic dysfunction is associated with brief episodes of atrial fibrillation in type 2 diabetes", J Diabetes Complications, 29, pp.88~92 (2015)[DOI]
73. Ziolo MT, "Defining the role of oxidative stress in atrial fibrillation and diabetes", J Cardiovasc Electrophysiol, 26, pp.223~225 (2015)[DOI]
74. Fatemi O, "Impact of intensive glycemic control on the incidence of atrial fibrillation and associated cardiovascular outcomes in patients with type 2 diabetes mellitus (from the action to control cardiovascular risk in diabetes study)", Am J Cardiol, 114, pp.1217~1222 (2014)[DOI]
75. Overvad TF, "Duration of diabetes mellitus and risk of thromboembolism and bleeding in atrial fibrillation: nationwide cohort study", Stroke, 46, pp.2168~2174 (2015)[DOI]
76. Chang SH, "Association of metformin with lower atrial fibrillation risk among patients with type 2 diabetes mellitus: a population-based dynamic cohort and in vitro studies", Cardiovasc Diabetol, 13, pp.123~ (2014)[DOI]
77. Nguyen TN, "Review of epidemiology and management of atrial fibrillation in developing countries", Int J Cardiol, 167, pp.2412~2420 (2013)[DOI]
78. Lip GYH, "The impact of associated diabetic retinopathy on stroke and severe bleeding risk in diabetic patients with atrial fibrillation: the loire valley atrial fibrillation project", Chest, 147, pp.1103~1110 (2015)[DOI]
79. Huxley RR, "Physical activity, obesity, weight change, and risk of atrial fibrillation: the atherosclerosis risk in communities study", Circ Arrhythm Electrophysiol, 7, pp.620~625 (2014)[DOI]
80. Murphy NF, "Long-term cardiovascular consequences of obesity: 20-year follow-up of more than 15 000 middle-aged men and women (the Renfrew-Paisley study)", Eur Heart J, 27, pp.96~106 (2006)[DOI]
81. Wanahita N, "Atrial fibrillation and obesity--results of a meta-analysis", Am Heart J, 155, pp.310~315 (2008)[DOI]
82. Wang TJ, "Obesity and the risk of new-onset atrial fibrillation", JAMA, 292, pp.2471~2477 (2004)[DOI]
83. Karason K, "Heart rate variability in obesity and the effect of weight loss", Am J Cardiol, 83, pp.1242~1247 (1999)[DOI]
84. Russo C, "Effect of obesity and overweight on left ventricular diastolic function: a community-based study in an elderly cohort", J Am Coll Cardiol, 57, pp.1368~1374 (2011)[DOI]
85. Visser M, "Elevated C-reactive protein levels in overweight and obese adults", JAMA, 282, pp.2131~2135 (1999)[DOI]
86. Overvad TF, "Body mass index and adverse events in patients with incident atrial fibrillation", Am J Med, 126, pp.640.e9~640.e17 (2013)[DOI]
87. Baek YS, "Delayed recurrence of atrial fibrillation 2years after catheter ablation is associated with metabolic syndrome", Int J Cardiol, 223, pp.276~281 (2016)[DOI]
88. Baek YS, "Associations of abdominal obesity and new-onset atrial fibrillation in the general population", J Am Heart Assoc, 6, pp.e004705~ (2017)[DOI]
89. Pathak RK, "Long-term effect of goal-directed weight management in an atrial fibrillation cohort: a long-term follow-up study (LEGACY)", J Am Coll Cardiol, 65, pp.2159~2169 (2015)[DOI]
90. Pathak RK, "Impact of CARDIOrespiratory FITness on arrhythmia recurrence in obese individuals with atrial fibrillation: the CARDIO-FIT study", J Am Coll Cardiol, 66, pp.985~996 (2015)[DOI]
91. Guijian L, "Impact of body mass index on atrial fibrillation recurrence: a meta-analysis of observational studies", Pacing Clin Electrophysiol, 36, pp.748~756 (2013)[DOI]
92. Jongnarangsin K, "Body mass index, obstructive sleep apnea, and outcomes of catheter ablation of atrial fibrillation", J Cardiovasc Electrophysiol, 19, pp.668~672 (2008)[DOI]
93. Sivasambu B, "Increased rates of atrial fibrillation recurrence following pulmonary vein isolation in overweight and obese patients", J Cardiovasc Electrophysiol, 29, pp.239~245 (2018)[DOI]
94. Zhuang J, "Influence of body mass index on recurrence and quality of life in atrial fibrillation patients after catheter ablation: a meta-analysis and systematic review", Clin Cardiol, 36, pp.269~275 (2013)[DOI]
95. Ector J, "Obesity is a major determinant of radiation dose in patients undergoing pulmonary vein isolation for atrial fibrillation", J Am Coll Cardiol, 50, pp.234~242 (2007)[DOI]
96. Shoemaker MB, "Relation of morbid obesity and female gender to risk of procedural complications in patients undergoing atrial fibrillation ablation", Am J Cardiol, 111, pp.368~373 (2013)[DOI]
97. Cha YM, "Catheter ablation for atrial fibrillation in patients with obesity", Circulation, 117, pp.2583~2590 (2008)[DOI]
98. Hoyt H, "Complications arising from catheter ablation of atrial fibrillation: temporal trends and predictors", Heart Rhythm, 8, pp.1869~1874 (2011)[DOI]
99. Letsas KP, "The impact of body mass index on the efficacy and safety of catheter ablation of atrial fibrillation", Int J Cardiol, 164, pp.94~98 (2013)[DOI]
100. Vizzardi E, "Obstructive sleep apnoea-hypopnoea and arrhythmias: new updates", J Cardiovasc Med (Hagerstown), 18, pp.490~500 (2017)[DOI]
101. Digby GC, "Sleep apnea and atrial fibrillation; 2012 update", Curr Cardiol Rev, 8, pp.265~272 (2012)[DOI]
102. Schotten U, "Pathophysiological mechanisms of atrial fibrillation: a translational appraisal", Physiol Rev, 91, pp.265~325 (2011)[DOI]
103. Lin YK, "Hypoxia and reoxygenation modulate the arrhythmogenic activity of the pulmonary vein and atrium", Clin Sci (Lond), 122, pp.121~132 (2012)[DOI]
104. Linz D, "Atrial fibrillation in obstructive sleep apnea: atrial arrhythmogenic substrate of a different sort", Am J Cardiol, 110, pp.1071~ (2012)[DOI]
105. Patel D, "Safety and efficacy of pulmonary vein antral isolation in patients with obstructive sleep apnea: the impact of continuous positive airway pressure", Circ Arrhythm Electrophysiol, 3, pp.445~451 (2010)[DOI]
106. Fein AS, "Treatment of obstructive sleep apnea reduces the risk of atrial fibrillation recurrence after catheter ablation", J Am Coll Cardiol, 62, pp.300~305 (2013)[DOI]
107. Naruse Y, "Concomitant obstructive sleep apnea increases the recurrence of atrial fibrillation following radiofrequency catheter ablation of atrial fibrillation: clinical impact of continuous positive airway pressure therapy", Heart Rhythm, 10, pp.331~337 (2013)[DOI]
108. Neilan TG, "Effect of sleep apnea and continuous positive airway pressure on cardiac structure and recurrence of atrial fibrillation", J Am Heart Assoc, 2, pp.e000421~ (2013)[DOI]
109. Li L, "Efficacy of catheter ablation of atrial fibrillation in patients with obstructive sleep apnoea with and without continuous positive airway pressure treatment: a meta-analysis of observational studies", Europace, 16, pp.1309~1314 (2014)[DOI]
110. Cowie MR, "Adaptive servo-ventilation for central sleep apnea in systolic heart failure", N Engl J Med, 373, pp.1095~1105 (2015)[DOI]
111. Hart RG, "Stroke prevention in atrial fibrillation patients with chronic kidney disease", Can J Cardiol, 29(7 Suppl), pp.S71~S78 (2013)[DOI]
112. Roldan V, "Renal impairment in a "real-life" cohort of anticoagulated patients with atrial fibrillation (implications for thromboembolism and bleeding)", Am J Cardiol, 111, pp.1159~1164 (2013)[DOI]
113. Lubitz SA, "Novel genetic markers associate with atrial fibrillation risk in Europeans and Japanese", J Am Coll Cardiol, 63, pp.1200~1210 (2014)[DOI]
114. Schnabel RB, "50 year trends in atrial fibrillation prevalence, incidence, risk factors, and mortality in the Framingham Heart Study: a cohort study", Lancet, 386, pp.154~162 (2015)[DOI]
115. Psaty BM, "Incidence of and risk factors for atrial fibrillation in older adults", Circulation, 96, pp.2455~2461 (1997)[DOI]
116. Selmer C, "The spectrum of thyroid disease and risk of new onset atrial fibrillation: a large population cohort study", BMJ, 345, pp.e7895~ (2012)[DOI]
117. Kim EJ, "Relation of hypothyroidism and incident atrial fibrillation (from the Framingham Heart Study)", Am Heart J, 167, pp.123~126 (2014)[DOI]
118. Vermond RA, "Incidence of atrial fibrillation and relationship with cardiovascular events, heart failure, and mortality: a community-based study from the Netherlands", J Am Coll Cardiol, 66, pp.1000~1007 (2015)[DOI]
119. Gami AS, "Obstructive sleep apnea, obesity, and the risk of incident atrial fibrillation", J Am Coll Cardiol, 49, pp.565~571 (2007)[DOI]
120. Baber U, "Association of chronic kidney disease with atrial fibrillation among adults in the United States: REasons for Geographic and Racial Differences in Stroke (REGARDS) Study", Circ Arrhythm Electrophysiol, 4, pp.26~32 (2011)[DOI]
121. Chamberlain AM, "Smoking and incidence of atrial fibrillation: results from the Atherosclerosis Risk in Communities (ARIC) study", Heart Rhythm, 8, pp.1160~1166 (2011)[DOI]
122. Larsson SC, "Alcohol consumption and risk of atrial fibrillation: a prospective study and dose-response meta-analysis", J Am Coll Cardiol, 64, pp.281~289 (2014)[DOI]
123. Aizer A, "Relation of vigorous exercise to risk of atrial fibrillation", Am J Cardiol, 103, pp.1572~1577 (2009)[DOI]

관련 논문AI추천